The regulation of mRNA deadenylation constitutes a pivotal mechanism of the post-transcriptional control of gene expression. Here we show that the antiproliferative protein Tob, a component of the Caf1-Ccr4 deadenylase complex, is involved in regulating the expression of the proto-oncogene c-myc. The c-myc mRNA contains cis elements (CPEs) in its 3 0 -untranslated region (3 0 -UTR), which are recognized by the cytoplasmic polyadenylation element-binding protein (CPEB). CPEB recruits Caf1 deadenylase through interaction with Tob to form a ternary complex, CPEB-Tob-Caf1, and negatively regulates the expression of c-myc by accelerating the deadenylation and decay of its mRNA. In quiescent cells, c-myc mRNA is destabilized by the trans-acting complex (CPEB-TobCaf1), while in cells stimulated by the serum, both Tob and Caf1 are released from CPEB, and c-Myc expression is induced early after stimulation by the stabilization of its mRNA as an 'immediate-early gene'. Collectively, these results indicate that Tob is a key factor in the regulation of c-myc gene expression, which is essential for cell growth. Thus, Tob appears to function in the control of cell growth at least, in part, by regulating the expression of c-myc.
INTRODUCTION
In eukaryotes, the mRNA poly(A) tail has pivotal roles in the posttranscriptional control of gene expression. The 3 0 poly(A) tail interacts with the 5 0 cap to circularize mRNA, which leads to a synergistic activation of translation.
1,2 Also, shortening of the poly(A) tail, termed deadenylation, is the rate-limiting step in general mRNA decay. 3 Thus, the regulation of the poly(A) tail length contributes greatly to the control of gene expression in terms of both translation and mRNA stability. 4, 5 Especially in oocyte maturation and early embryonic development, which occur in the absence of transcription, gene expression is absolutely regulated by the polyadenylation and deadenylation of maternal mRNA. In this case, CPE-containing pre-mRNA such as cyclin B1 acquires a long poly(A) tail in the nucleus that is subsequently shortened when transported to the cytoplasm. The poly(A) tail length is controlled by two cytoplasmic polyadenylation element-binding protein (CPEB)-associated proteins: a poly(A)-specific ribonuclease (PARN) deadenylase 6 and a poly(A) polymerase Gld2. 7 CPEB recruits PARN to the CPEcontaining mRNA and accelerates the deadenylation reaction. Upon oocyte maturation, CPEB phosphorylation leads to the dissociation of PARN from the RNP complex and instead Gld2 associated with CPEB catalyzes default polyadenylation. 8 Thus, cytoplasmic polyadenylation activates the translation of specific mRNAs.
In somatic cells, however, poly(A) tail length is regulated mostly by deadenylation that is generally catalyzed by two major mRNA deadenylase complexes, Pan2-Pan3 and Caf1-Ccr4. 9 The former consists of the catalytic subunit Pan2 and regulatory subunit Pan3. 10 Pan3 binds to the poly(A)-binding protein PABPC1 by using the PAM2 motif and makes Pan2 accessible to the substrate poly(A), which leads to the activation of deadenylation. 10 On the other hand, both the Caf1 and Ccr4 subunits of the latter complex have the catalytic activities of the deadenylase. [11] [12] [13] The antiproliferative protein Tob forms a complex with Caf1-Ccr4 14 and mediates the binding of the deadenylases to PABPC1. 15 As in the case of Pan3, Tob binds to PABPC1 via the PAM2 motif and makes Caf1-Ccr4 accessible to the PABPC1-bound poly(A), which also leads to the activation of deadenylation. 16, 17 We have previously found that the termination of translation triggers mRNA deadenylation, and proposed an initiation mechanism of mRNA decay: after translation termination, the termination complex eRF1-eRF3 is released from PABPC1, and in turn the two deadenylase complexes, Pan2-Pan3 and Caf1-Ccr4, bind to PABPC1 to degrade the poly(A) tail of the mRNA. 17 The translation termination factor eRF3 also contains PAM2 motifs, and competition between eRF3 and the two deadenylase complexes for the binding of PABPC1 is the key to this model. 17, 18 In addition to the decay of general mRNA, Tob in a complex with Caf1 also has an important role in the regulation of specific mRNA. Tob binds directly to a sequence-specific RNA-binding protein, CPEB3, and recruits Caf1 to the target of CPEB3. 19 The binding of CPEB3 to the target, AMPA receptor (GluR2) mRNA, leads to accelerated deadenylation and decay of the message and inhibition of its expression. Thus, Tob is thought to function in learning and memory by regulating the expression of the AMPA receptor.
and T-cell activation. 27 Among its known biological functions, Tob's role as a negative regulator of the cell cycle is well established. Ectopic expression of Tob or its paralog Tob2 results in the inhibition of cell proliferation. 14, 22, 23 Tob suppresses cyclin D1 expression upstream of Rb phosphorylation and inhibits G1-to-S phase transition. 23 However, the role of Tob in mRNA deadenylation with respect to cell growth regulation remains to be determined.
Here, we show that Tob directly regulates c-myc oncogene expression during G1-to-S phase transition. In quiescent cells, Tob forms a ternary complex CPEB-Tob-Caf1 and recruits Caf1 deadenylase to the target c-myc mRNA to degrade rapidly the message. After serum stimulation, Tob and Caf1 dissociate from CPEB, which leads to the stabilization of the mRNA and activation of its gene expression. Thus, Tob appears to function in the control of cell growth at least, in part, by regulating the expression of c-myc.
RESULTS
Tob directly binds CPEB to form a ternary complex with Caf1 deadenylase We have previously shown that Tob directly binds to form a complex with the sequence-specific RNA-binding proteins CPEB3 and CPEB4. 19 Detailed analysis of the interaction revealed that Tob binds to the carboxyl-terminal RNA-binding domain of CPEB3/ 4. Since the RNA-binding domain is highly conserved among CPEB2-4 (495% identity), and distantly related CPEB still has a homologous domain (B40-50% identity), we speculated that Tob also binds to CPEB. Thus, we first examined the interaction with a glutathione S-transferase (GST) pull-down assay. GST-Tob (1-285) and MBP-CPEB, which had been prepared from Escherichia coli with 495% purity, were mixed and pulled down by glutathione sepharose beads. Western blot analysis with anti-MBP antibody revealed the presence of MBP-CPEB, while it was not detected in the control experiment with GST ( Figure 1a) . The interaction was further confirmed with co-immunoprecipitation experiment. When lysate of HeLa cells expressing 5 Â Flag-CPEB, 5 Â Myc-Tob and 5 Â Myc-Caf1 was immunoprecipitated with anti-Flag antibody, the precipitated fraction contained 5 Â Myc-Tob (Figure 1b) . Also, we have confirmed the presence of 5 Â Myc-Caf1 in the precipitate. The precipitated amount of 5 Â Myc-Caf1 was increased when 5 Â Myc-Tob was expressed (Figure 1b , compare lanes 5 and 6). These interactions seemed not to be mediated by RNA since the binding experiments were performed in the presence of RNase A. These results indicate that Tob directly binds CPEB, as in the case of CPEB3 and CPEB4, to form a ternary complex with Caf1 deadenylase.
CPEB represses expression of c-myc 3 0 -UTR reporter gene by destabilizing its mRNA The observed interaction between CPEB, Tob and Caf1 led us to speculate that CPEB's target mRNAs are regulated by deadenylation. Previous study has shown that c-myc mRNA, which contains CPEs and CPE-like sequences in its 3 0 -UTR (Figure 2a ), is one of the targets of CPEB. 28 In an attempt to determine the significance of the interaction between CPEB, Tob and Caf1, a bglobin gene (BGG) reporter appended with the c-myc 3 0 -UTR (cmyc 3 0 -UTR reporter) was constructed, and the effect of CPEB on the expression of the reporter was examined by western and northern blot analyses. Exogenously expressed CPEB significantly lowered the level of BGG reporter protein in a dose-dependent manner (Figures 2b and d) . This result seems not merely to be a consequence of translational repression because CPEB also reduces the level of the reporter mRNA (Figures 2c and e ). The steady-state level of the reporter mRNA was reduced to B30% by CPEB (Figure 2e ), where that of the protein was reduced to B5% (Figure 2d ), suggesting that CPEB negatively regulates the reporter gene expression also at the mRNA level. The ability of CPEB to reduce the reporter mRNA and protein expression is dependent on its binding to the mRNA, as CPEB did not significantly affect the expression of the reporter gene with mutated CPEs (Figures 2b  and c, lanes 4-6) .
To determine whether CPEB reduces the c-myc mRNA level by promoting mRNA decay, we conducted a transcriptional pulse-chase analysis by using Tet-on system (Figure 2f ). The BGG with the c-myc 3 0 -UTR (c-myc 3 0 -UTR reporter) was placed under the control of the 'Tet-on' promoter. Transcription was allowed to proceed for 2 h by adding tetracycline in T-REx HeLa cells. Cells were then washed three times to block further transcription, and total RNA was prepared from the cells sequentially after transcription was shut off. Northern blot analysis showed that the stability of c-myc 3 0 -UTR reporter mRNA was decreased approximately twofold by the presence of CPEB (Figures 2f and g ). The signal intensity of the band was quantified along the length of the mRNA and plotted as a function of mRNA size (Figure 2h Figure S1) . From these results, we conclude that CPEB accelerates deadenylation and decay of c-myc mRNA. We note that these results are not due to a secondary or nonspecific effect of CPEB, as CPEB alone did not accelerate the decay of a reporter mRNA appended with MS2-binding sites in its 3 0 -UTR but without CPEs (Supplementary Figure S2) . On the other hand, MS2-CPEB increased the rate of deadenylation and decay for the reporter mRNA (Supplementary Figure S2) . These observations further confirm that CPEB promotes deadenylation and decay of c-myc mRNA through its binding to the 3 0 -UTR.
Caf1 is responsible for the CPEB-accelerated decay of c-myc 3 0 -UTR mRNA Next, we sought to determine whether the CPEB-accelerated decay of c-myc 3 0 -UTR reporter mRNA was mediated by Caf1 deadenylase. For this purpose, we applied a dominant-negative approach. T-REx HeLa cells were co-transfected with the c-myc 3 0 -UTR plasmid and a plasmid expressing CPEB, with or without a plasmid expressing a nuclease-deficient Caf1 mutant in which a catalytically essential aspartate residue was mutated to alanine (Caf1 D161A), and a transcriptional pulse-chase analysis was performed. The Caf1 mutant almost completely blocked CPEBaccelerated deadenylation and decay of the c-myc 3 0 -UTR reporter mRNA (Figures 3a and b) . In contrast, a Pan2 mutant c-myc 3'UTR BGG c-myc 3'UTR mRNA Tob regulates c-myc mRNA stability via CPEB K Ogami et al (Pan2 D1083A) that had no deadenylase activity showed no apparent effect. The expression of comparable amounts of Caf1 D161A and Pan2 D1083A was confirmed by western blotting (Figure 3e ).
In this relation, CPEB is known to bind another deadenylase PARN to regulate deadenylation of its target mRNA in the Xenopus oocyte. 8 The interaction was recapitulated between humanderived CPEB and PARN (Supplementary Figure S3) . When lysate of HeLa cells expressing 5 Â Flag-CPEB and 5 Â Myc-PARN was immunoprecipitated with anti-Flag antibody, the precipitated fraction contained 5 Â Myc-PARN. However, overexpression of a PARN mutant (PARN D28A) that had no deadenylase activity 29 showed no effect on CPEB-accelerated deadenylation and decay of the c-myc 3 0 -UTR reporter mRNA (data not shown). Collectively, these results indicate that CPEB-accelerated deadenylation and decay of the c-myc 3 0 -UTR reporter mRNA is dependent on the deadenylase activity of Caf1.
To confirm that Tob is involved in the CPEB-accelerated c-myc mRNA decay, small interfering RNA (siRNA)-mediated knockdown was performed. In this case, Tob and Tob2, a highly homologous paralogue of Tob, were depleted simultaneously ( Figure 3f ). As shown in Figures 3c and d , depletion of Tob/Tob2 significantly reduced the rate of mRNA decay of the c-myc 3 0 -UTR reporter.
Tob and CPEB negatively regulate endogenous c-myc expression at the mRNA level We next examined if Tob as well as CPEB is actually involved in the regulation of endogenous c-myc mRNA. For this purpose, we used U2OS cells, as CPEB, Tob and Caf1. Proteins were all expressed in this cell line at a level sufficient for detection using our antibodies (Figure 4a ). CPEB and Tob were depleted by siRNA-mediated knockdown, and the expression of c-myc was examined at both the mRNA and protein level. Depletion of Tob/Tob2 resulted in an
GST-CAT mRNA Tob/Tob2 and CPEB negatively regulate the stability of endogenous c-myc mRNA in starved cells and the effects are abrogated by serum stimulation It is well established that the level of c-myc mRNA depends upon the cellular growth state. In serum-starved cells, c-myc mRNA is expressed at a very low level. When cells are stimulated by serum, the abundance of c-myc mRNA starts to rise, and peaked within 1 and 2 h, followed by a decline and a plateau at several fold the levels in starved cells. 30 The transcription level reaches a peak before that of the c-myc mRNA level. As both Tob and CPEB regulate cell cycle progression, we examined whether these factors are involved in the serum-induced immediate-early response of c-myc gene expression (Figures 5b and c) . To measure changes in the level of c-myc transcription and mRNA abundance at the same time, we performed a real-time polymerase chain reaction (PCR) analysis using two pairs of PCR primers (Figure 5a ) and reverse transcription (RT) products of total RNA prepared from U2OS cells as a template. The primer pair a-c amplifies c-myc mature mRNA (cytoplasmic mRNA), whereas primer pair b and c amplifies c-myc pre-mRNA (nuclear mRNA). The pre-mRNA level generally reflects transcription. It is important to note that even after 35 thermal cycles, no amplification was observed when mock RT products prepared without reverse transcriptase were used as a template, and that these primer pairs amplify only a single band (Supplementary Figure S4A and data not shown). As shown in SupplementaryFigure S4B, the c-myc transcription and mRNA abundance measured in this assay system faithfully recapitulated the fluctuations previously reported upon serum stimulation, further validating the specificity of the primer pairs. Similar to the results from the steady-state analysis in Figure 4 , knockdown of either Tob/Tob2 or CPEB resulted in a marked increase in c-myc mature mRNA in starved cells (Figure 5b , mature mRNA, starved, Po0.05). However, the effect was attenuated at 1 h after serum stimulation (Figure 5b ; mature mRNA, stimulated), suggesting that Tob/Tob2 and CPEB negatively regulate the level of c-myc mRNA under starved conditions and the effects are abrogated by serum stimulation. Analysis of pre-mRNA revealed that knockdown of Tob/Tob2 but not CPEB increased c-myc transcription slightly but significantly in starved condition (Figure 5b ; premRNA, Po0.05). This result explains why c-myc mRNA was more abundant in Tob/Tob2 knockdown cells than in CPEB knockdown cells (Figure 4d ). Figure 5c shows the same result as in Figure 5b , but the y axis represents the fold-increase of c-myc mature or premRNA in serum-stimulated cells relative to starved cells. In control siRNA-treated cells, c-myc mature mRNA was increased by B7-fold (Figure 5c , Luc, 2nd column). Knockdown of either Tob/ Tob2 or CPEB reduced c-myc mRNA induction by B3-fold after serum stimulation (Figure 5c ; Tob/Tob2, CPEB, 2nd column, Po0.005). In contrast, there were no significant differences in the induction of c-myc pre-mRNA among these cells (Figure 5c ; Tob/Tob2, CPEB, 4th column). Consistent with fluctuations of c-myc mRNA, c-Myc protein was increased by knockdown of either Tob or CPEB in starved cells (Figures 5d and e) . Also, serumstimulated induction of c-Myc protein was inhibited by their knockdowns (Figures 5d and f) . These results strengthen our conclusion that CPEB and Tob regulate the expression of c-Myc at the level of mRNA. Tob regulates c-myc mRNA stability via CPEB K Ogami et al
The above results led us to speculate that both Tob/Tob2 and CPEB are involved in the induction of c-myc mRNA expression after serum stimulation in a process of controlling mRNA stability. To investigate this possibility, we first examined if there are changes in c-myc mRNA stability after serum stimulation. Serumstarved U2OS cells were pre-treated with actinomycin D for 15 min, and then stimulated with serum or left untreated (starved).
Actinomycin D was maintained in the medium throughout the time course. Total RNA was isolated every 15 min after serum was added and analyzed by real-time PCR. As shown in Figure 5g , the half-life of c-myc mRNA was about 2.3-fold longer in stimulated cells than starved cells. Thus, we next estimated the half-life of c-myc mRNA in serum-starved quiescent cells that were treated with siRNA against either Tob/Tob2 or CPEB (Figures 5h and i) . 
DISCUSSION
Tob is a member of the BTG/Tob family of antiproliferative proteins, which regulates cell cycle progression in a variety of cell types. Previous study demonstrated that Tob is involved in the control of G1-to S-phase transition of the cell cycle. 22, 23 On the other hand, we and others have demonstrated that Tob functions in deadenylation of both general 16, 17 and specific 19 mRNAs. However, the role of Tob in mRNA deadenylation with respect to cell growth regulation has remained to be determined.
This study provides evidence that Tob mediates deadenylation of c-myc mRNA and negatively regulates its expression. In serumstarved quiescent state, Tob mediates recruitment of Caf1 deadenylase to the CPEB-bound c-myc mRNA and accelerates deadenylation and decay of the mRNA. While in cells stimulated pCMV-5×Myc-Tob pCMV-5×Myc-Tob 0 -UTR recruits the Tob-Caf1 complex to the mRNA to form a ternary complex, which leads to accelerated deadenylation and decay of the message. Upon serum stimulation, Tob and Caf1 transiently dissociate from CPEB and c-myc mRNA is stabilized and expressed as an 'immediate-early response gene' .
Tob regulates c-myc mRNA stability via CPEB K Ogami et al by serum, Tob in a complex with Caf1 dissociates from CPEBbound c-myc mRNA, which leads to a transient stabilization of the message and immediate-early expression of c-Myc (Figure 7) . Thus, Tob appears to function in the control of cell growth at least, in part, by regulating the expression of c-myc.
It has been reported that CPEB activates translation of CPEcontaining mRNAs (for example, aCAMKII and p53) by promoting cytoplasmic polyadenylation of the messages. 31, 32 In contrast, no CPE-containing mRNA that is subject to accelerated deadenylation by CPEB has been reported in mammalian somatic cells. To our knowledge, c-myc is the first example of such an mRNA. Therefore, it was surprising that tethering CPEB to mRNA 3 0 -UTR led to accelerated deadenylation and decay of the mRNA (Supplementary Figure S2) , which is reminiscent of c-myc, but neither aCAMK2 nor p53. Moreover, reporter mRNAs appended with other CPEB-target 3 0 -UTR, such as c-jun 3 0 -UTR, 33 were not affected by overexpression of CPEB (data not shown). Thus, CPEB does not necessarily induce polyadenylation (or deadenylation) of CPE-containing mRNAs by default. It remains unknown what determines whether CPEB-bound mRNAs will be degraded by accelerated deadenylation or translationally activated by cytoplasmic polyadenylation. In Xenopus oocytes, not every CPEcontaining mRNA is translationally activated at the same time during meiosis after progesterone treatment. The positional distribution and the number of CPE sequences, as well as the arrangement of other cis-acting elements, such as AU-rich element, 34 Musashi-binding element, 35 Pumilio-binding element 36 and translational control sequence, 37 around CPEs define the extent and timing of translational activation. 38 Moreover, translational repression by CPEB requires a cluster of at least two CPEs with an optimal distance of 10-12 nucleotides. 36 This finding implies that the recruitment of the translational repressor maskin is mediated by a CPEB dimer formed on two adjacent CPEs. It is possible that such factors are involved in the determination of the fate of CPE-containing mRNAs in mammalian somatic cells. We are currently investigating this possibility.
c-Myc is a basic helix-loop-helix leucine zipper transcription factor and is required for the activation of cyclin D-dependent kinases and G0/G1-to S-phase transition. 39 Numerous studies have documented that the c-myc oncogene is expressed immediately after growth stimulation of quiescent cells and is essential for the regulation of cell growth. In most cases, changes measured in the rate of c-myc gene transcription are insufficient to account for the fluctuations and even no significant change in the rate of transcription was detectable in some cells. 30, 40, 41 These results suggest that the changes in c-myc expression during G0/ G1-to S-phase transition are controlled by a post-transcriptional mechanism. However, this mechanism has remained to be determined for over 20 years. The results presented here provide one answer to this long-standing question.
Activation of c-myc gene expression after mitogenic stimulation is mediated by the Ras/Raf/mitogen-activated protein kinase pathway. 42 In this relation, previous study demonstrated that Tob is phosphorylated at serine residues by mitogen-activated protein kinase (Erk1/Erk2) downstream of the Ras signaling pathway. 22, 23 These results led us to speculate that serum activates Rasmitogen-activated protein kinase signaling pathways and the Erkmediated phosphorylation of the serine residues of Tob is responsible for the dissociation of Tob from CPEB and stabilization of c-myc mRNA. However, mutant Tob with either serine-to-alanine or serine-to-glutamate mutations at the Erk phosphorylation sites (Ser 152, 154 and 164) bound CPEB with similar affinity to wild-type Tob and still showed dissociation from CPEB upon serum stimulation (data not shown). Previous study demonstrated that Tob is phosphorylated at at least three serine/ threonine residues other than Ser 152, 154 and 164 upon mitogenic stimulation. 23 Thus, phosphorylation of residues other than the three serine residues or other modifications of Tob and/ or CPEB seem to be responsible for the dissociation of the complex.
In addition to Tob and c-Myc, CPEB and Caf1 are also known to be involved in cell cycle regulation. (i) siRNA-mediated knockdown of CPEB results in an increase in astrocytic cell proliferation, whereas overexpression of CPEB inhibits it. 43 On the other hand, similar CPEB knockdown shows proliferation defects in HeLa cells. 44 (ii) siRNA-mediated knockdown of Caf1 leads to a defect in both G1-to S-phase transition and cell proliferation, 45 while overexpression of Caf1 also inhibits cell proliferation. 46 Thus, as in the case for Tob, Caf1 and CPEB also inhibit cell proliferation when overexpressed in cells, but the phenotypes resulting from siRNAmediated knockdowns are divergent depending on cell types and on each component. Since CPEB also regulates cytoplasmic polyadenylation of cell cycle regulators (for example, CDKN3, Mnt, STXBP2, and so on) and Caf1 regulates transcription and deadenylation of general mRNAs, the effect on proliferation resulting from the modulation of these components might not be unidirectional.
Previous studies have shown that CPEB promotes polyadenylation-induced translational activation of cyclin B1 mRNA in the M phase and maskin-mediated translational repression in the S phase of early mitotic cell divisions in Xenopus embryos. 47 In contrast to the early embryonic divisions without intervening G1 and G2 phases, CPEB also regulates G2-to M-phase transition of mitotically dividing cells by mediating cytoplasmic polyadenylation of specific mRNAs, including CDKN3 and Cdc20. 44 In this study, we have shown that CPEB-mediated deadenylation and decay of c-myc mRNA might also be important for the regulation of G0/G1-to S-phase transition of the cell cycle. Remaining questions that we are currently pursuing are whether CPEB promotes cytoplasmic polyadenylation not only in the M phase but also during G0/G1-to S-phase transition and whether c-myc mRNA is polyadenylated in response to serum stimulation in a CPEB-dependent manner. These will be the subjects of forthcoming papers.
MATERIALS AND METHODS Plasmids
To construct pHA-CMV5-CPEB, pCMV-5 Â Myc-CPEB, pCMV-5 Â Flag-CPEB, pMAL-cRI-CPEB and pGEX6P1-CPEB, the full-length open reading frame was PCR-amplified using the primers: sense, 5 0 -TTTCAATTGATG GCGTTCCCGCTGGAA-3 TGCAGGTGAG-3 0 , respectively, and pFlag-CMV5/TO-BGG c-myc 3 0 -UTR as a template. The amplified fragments were mixed and used as a template for the second PCR conducted to generate full-length c-myc 3 0 -UTR fragment. The resulting fragment was digested with HindIII and PstI and inserted into pFlag-CMV5/TO-BGG 3 0 -UTR(HindIII). The construction of pGEX6P1-Tob (1-285), pCMV-5 Â Myc-Pan2 D1083A and pCMV-5 Â Myc Caf1 D161A was described previously. 19 
siRNA
The sequences of siRNAs for luciferase, Tob and Tob2 were described previously. 19 Anti-Caf1 (for immunoprecipitation), anti-CPEB and anti-PABPC1 were raised against His-tagged full-length proteins. Anti-Caf1 was a gift from Ann-Bin Shyu. 16 Cell culture and transfection HeLa, T-REx HeLa and U2OS cells were cultured in Dulbecco's modified Eagle's medium (Nissui, Tokyo, Japan) supplemented with 5% fetal bovine serum. U2OS cells were purchased from ATCC. DNA transfection was performed using Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA) as described previously. 17 For siRNA transfection, Lipofectamine RNAi MAX (Invitrogen) was used. For transfection with both siRNA and plasmid DNA, cells were first transfected with siRNA using RNAi MAX. After 24 h, cells were trypsinized, and re-cultured for another 24 h before DNA transfection using Lipofectamine 2000. Following further incubation for 24 h, pulsechase experiments were conducted.
Immunoprecipitation
For immunoprecipitations, cells were lysed with 10 mg/ml RNaseA (Sigma) or 50 U/ml RNase I (New England Biolaboratories) in lysis buffer consisting of 50 mM Tris-HCl (pH 7.5), 50 mM NaCl, 0.25% Nonident P-40, 1 mM dithiothreitol, 2.5 mM ethylenediaminetetraacetic acid, 20 mM NaF, 10 mM Na 4 P 2 O 7 , 0.1 mM phenylmethanesulfonylfluoride, 2 mg/ml aprotinin, and 2 mg/ml leupeptin. After centrifugation at 15 000 g for 20 min, the supernatant was incubated for 2 h at 4 1C with anti-Flag IgG agarose (Sigma), or anti-Myc agarose (Sigma). The resin was then washed three times with lysis buffer, and proteins retained on the resin were subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis and western blot analysis.
GST-pull-down assay GST-fused Tob and MBP-CPEB were produced in E. coli BL21 by adding 0.4 mM isopropylthio-b-galactoside and purified as described previously. 19 GST-fused Tob and MBP-CPEB were incubated with glutathione sepharose 4B (GE Healthcare) for 2 h at 4 1C in binding buffer (20 mM Tris-HCl (pH 7.5), 50 mM NaCl, 0.5% Nonident P-40, 1 mM dithiothreitol, 2.5 mM ethylenediaminetetraacetic acid). The resin was then washed three times with binding buffer. Bound proteins were eluted with sodium dodecyl sulfate-polyacrylamide gel electrophoresis sample buffer and analyzed by western blotting.
Northern blot analysis
The northern blot analysis, transcriptional pulse-chase analysis and oligo (dT)-RNase H treatment of mRNA to generate poly(A)
À mRNA were performed as described previously, 19 except that the pulse transcription was induced by 10 ng/ml tetracycline for 2 h.
Real-time PCR analysis
Cells were directly harvested (steady-state level) or treated with 10 mg/ml actinomycin D (mRNA decay) and harvested at indicated times. Total RNA was isolated by the acid guanidinium-phenol-chloroform method with minor modifications and genomic DNA was removed by digestion with DNase I for 30 min. Random-primed RT of RNA (1.5 mg) was performed using SuperScript III Reverse Transcriptase (Invitrogen). Real-time PCR analysis was performed using StepOne Real-Time PCR system with PowerSYBR Green PCR Master Mix (Applied Biosystems, Foster City, CA, USA). Changes in c-myc mRNA levels were determined by the relative standard curve method using GAPDH mRNA for internal normalization. The primers for GAPDH were described previously. 19 c-myc mRNA was amplified using primers: sense, 5 0 -TTCGGGTAGTGGAAAACCAG-3 0 and antisense, 5 0 -GGAACTATGACCTCGACTACGACT-3 0 . C-myc pre-mRNA was amplified using: sense, 5 0 -GCACCAAGACCCCTTTAACT-3 0 and antisense, 5 0 -GGAAC;TATGACCTCGACTACGACT-3 0 . The specificity of the primer pairs and genomic DNA digestion were checked by PCR analysis using KOD FX (TOYOBO, Osaka, Japan) or PowerSYBR Green (Applied Biosystems).
